Announcement on Voluntary Disclosure of Marketing Authorization Approval Received for Dolutegravir Sodium Active Pharmaceutical Ingredient

About this update from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

Announcement on Voluntary Disclosure of Marketing Authorization Approval Received for Dolutegravir Sodium Active Pharmaceutical IngredientThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A